(Q56900652)

1

0 references

Y K Yong

2

0 references

H Y Tan

3

0 references

A Kamarulzaman

4

0 references

L H Tan

5

0 references

A Lim

6

0 references

I James

7

0 references

P Price

Immunological recovery and antiretroviral therapy in HIV-1 infection

9

0 references

language of work or name

English

0 references

publication date

May 2008

0 references

published in

HIV Medicine

0 references

volume

9

0 references

issue

5

0 references

page(s)

307-16

0 references

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Immune restoration under HAART in patients chronically infected with HIV-1: diversity of T, B, and NK immune responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Immune restoration disease after antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Cryptococcal immune reconstitution inflammatory syndrome: report of four cases in three patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Proportions of circulating T cells with a regulatory cell phenotype increase with HIV-associated immune activation and remain high on antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Optimal T cell responses to Cryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

A pilot study of the discontinuation of antifungal therapy for disseminated cryptococcal disease in patients with acquired immunodeficiency syndrome, following immunologic response to antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Mycobacterial immune reconstitution inflammatory syndrome in HIV-1 infection after antiretroviral therapy is associated with deregulated specific T-cell responses: beneficial effect of IL-2 and GM-CSF immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

Plasma bioavailable interleukin-6 is elevated in human immunodeficiency virus-infected patients who experience herpesvirus-associated immune restoration disease after start of highly active antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X

The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2008.00565.X